Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- TRY 256.87T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | TRY 239.3B | TRY 681.90 | 2.66% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | TRY 464.2B | TRY 4,887.77 | 3.30% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | TRY 329.1B | TRY 4,852.47 | 0.11% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | TRY 265.3B | TRY 6,288.39 | 0.76% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | TRY 199.8B | TRY 1,459.37 | 1.51% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | TRY 377.8B | TRY 4,808.08 | 0.23% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | TRY 248.3B | TRY 4,409.13 | 0.51% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | TRY 503.8B | TRY 3,333.08 | 5.38% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | TRY 1.19T | TRY 1,042.26 | 1.05% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | TRY 1.41T | TRY 1,944.82 | 0.39% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | TRY 230.8B | TRY 2,107.72 | 0.59% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | TRY 388.3B | TRY 1,114.39 | 4.62% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | TRY 2.01T | TRY 3,501.28 | 1.08% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | TRY 2.48T | TRY 2,126.64 | 1.07% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | TRY 1.6T | TRY 2,598.22 | 0.86% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | TRY 435.4B | TRY 15,577.22 | 1.24% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | TRY 398.2B | TRY 2,369.49 | 3.37% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | TRY 3.45T | TRY 1,079.08 | 1.13% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | TRY 17.22T | TRY 6,985.00 | 3.40% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | TRY 415B | TRY 6,357.99 | 1.11% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | TRY 247.9B | TRY 2,582.33 | 0.20% up | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | TRY 303.5B | TRY 15,172.47 | 2.39% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | TRY 33.44T | TRY 13,891.39 | 1.18% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | TRY 799.9B | TRY 12,462.01 | 2.65% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | TRY 4.95T | TRY 47,819.57 | 1.01% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | TRY 62.71T | TRY 70,399.86 | 1.39% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | TRY 6.21T | TRY 3,036.76 | 1.86% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | TRY 322.9B | TRY 7,950.26 | 0.06% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | TRY 304.3B | TRY 4,661.57 | 0.52% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | TRY 899.4B | TRY 13,712.09 | 0.25% up | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | TRY 6.89T | TRY 27,185.87 | 0.90% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | TRY 25.65T | TRY 14,508.73 | 1.76% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | TRY 14.86T | TRY 7,870.06 | 1.94% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | TRY 1.25T | TRY 29,400.77 | 0.20% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | TRY 679.9B | TRY 1,360.26 | 4.33% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | TRY 768B | TRY 3,942.60 | 1.78% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | TRY 2.33T | TRY 20,440.28 | 1.93% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | TRY 8.11T | TRY 1,422.05 | 0.97% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | TRY 419.8B | TRY 6,055.37 | 2.96% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | TRY 591.8B | TRY 3,055.30 | 3.53% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | TRY 310B | TRY 2,192.97 | 1.14% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | TRY 4.94T | TRY 2,462.29 | 0.85% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | TRY 632.8B | TRY 759.00 | 1.75% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | TRY 14.06T | TRY 9,063.89 | 1.40% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | TRY 290.6B | TRY 426.94 | 1.91% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | TRY 5.73T | TRY 2,387.94 | 0.39% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | TRY 357.2B | TRY 6,790.73 | 0.96% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | TRY 377B | TRY 3,444.29 | 2.54% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | TRY 8.81T | TRY 1,999.54 | 2.59% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | TRY 9.13T | TRY 5,271.09 | 0.19% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | TRY 254.4B | TRY 3,045.34 | 0.03% up | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | TRY 362.9B | TRY 2,605.28 | 0.01% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | TRY 247.6B | TRY 1,422.81 | 1.29% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | TRY 478.2B | TRY 20,584.27 | 3.29% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | TRY 370.9B | TRY 4,236.64 | 2.31% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | TRY 1.74T | TRY 4,294.39 | 1.99% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | TRY 425B | TRY 531.35 | 1.27% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | TRY 1.34T | TRY 6,087.14 | 0.96% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | TRY 158.9B | TRY 819.08 | 0.81% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | TRY 234B | TRY 1,404.90 | 3.32% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | TRY 1.02T | TRY 7,616.87 | 3.50% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4362 TRY).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 18:41 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of TRY 256.87T as of 18 Nov 2026, 18:41 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.